META Form 4: Olivan RSU vesting, tax-withheld shares and planned sales
Rhea-AI Filing Summary
Javier Olivan, Chief Operating Officer of Meta Platforms, reported multiple share and restricted stock unit (RSU) transactions in mid-August 2025. On 08/15/2025 he had RSUs settle and received net share issuances (totaling 16,902 RSUs converted to Class A shares across several grants) while the issuer withheld 5,396 and 2,612 shares to satisfy tax withholding in connection with net settlement. He also sold 2,612 shares at $782.13 (withheld per explanation) and on 08/18/2025 sold 517 shares at $775 under a Rule 10b5-1 trading plan adopted August 17, 2024. Following these transactions, his reported beneficial ownership of Class A common stock includes direct and indirect holdings totaling approximately 130,000+ shares across personal entities and a family trust (examples: 90,493 shares held by a family trust; direct holdings of 10,221 and 13,645 reported after certain transactions). The filings show routine executive compensation vesting, tax-withholding settlements, and planned sales under a 10b5-1 plan rather than opportunistic market sales.
Positive
- RSU settlements increased reported ownership through multiple vested grants settled on 08/15/2025 (aggregate issued RSU shares disclosed)
- Transactions include issuer tax withholding for RSU net settlement rather than open-market forced sales
- Sale on 08/18/2025 executed under an established Rule 10b5-1 plan, indicating pre-planned trading intent
Negative
- Officer executed small open-market sales (2,612 shares at $782.13 and 517 shares at $775), which reduce direct holdings
- Significant portion of holdings held indirectly via family trust and LLCs, which can complicate immediate transparency of economic exposure
Insights
TL;DR: Mid-August RSU settlements increased Olivan's reported stake while small planned sales and tax withholding explain share reductions; overall routine, not material.
The Form 4 shows standard executive compensation mechanics: multiple RSU grants vested and settled on 08/15/2025, producing share issuances and corresponding tax-withholding by the issuer rather than open-market sales. Two small open-market sales (2,612 shares at $782.13 and 517 shares at $775) were executed, the latter under an existing Rule 10b5-1 plan. These volumes are small relative to institutional float and the company size, and the transactions reflect routine liquidity and tax settlement activity rather than a change in corporate outlook. No new debt, litigation, or other material events are disclosed.
TL;DR: Disclosure aligns with governance expectations: RSU vesting, issuer tax withholding, and 10b5-1-plan sales are properly reported.
The Form 4 provides clear provenance for each transaction: net settlements to satisfy tax obligations are explicitly identified, and the sale on 08/18/2025 is tied to a Rule 10b5-1 plan adopted 08/17/2024, which supports affirmative defense compliance. Beneficial ownership is broken out across direct, indirect, and trust holdings, with explanatory footnotes clarifying managerial roles for LLCs and the family trust. No indications of undisclosed related-party transfers or unusual timing are present in the filing.
FAQ
What transactions did META COO Javier Olivan report on Form 4?
Were the 08/18/2025 sales by Javier Olivan part of a 10b5-1 plan?
Why were some shares withheld in the RSU settlements?
How many shares does Olivan beneficially own after these transactions?
Do these Form 4 entries indicate material company-level events for META investors?